Theravance Biopharma, Inc. (TBPH)
19.51
-0.97
(-4.74%)
USD |
NASDAQ |
Feb 09, 16:00
19.51
0.00 (0.00%)
After-Hours: 20:00
Theravance Biopharma Profit Margin (Quarterly) : 18.08% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 9.32% |
| Nektar Therapeutics | -301.3% |
| Innoviva, Inc. | 80.81% |
| Oramed Pharmaceuticals, Inc. | -- |
| Skye Bioscience, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 14.90% |
| Return on Assets | 7.74% |
| Return on Invested Capital | 11.74% |
| Gross Profit Margin (Quarterly) | 92.96% |
| Operating Margin (Quarterly) | -32.29% |
| Return on Net Operating Assets | 46.77% |